Projected to be valued at US$ 108.1 billion in 2023, the anti-counterfeit pharmaceutical packaging market anticipates substantial growth. Forecasts indicate a robust trajectory, with expectations to reach US$ 246.6 billion by 2033, reflecting a noteworthy Compound Annual Growth Rate (CAGR) of 8.6%. This surge is attributed to the increasing emphasis on securing pharmaceutical supply chains and combating counterfeit activities. Regulatory measures, technological advancements, and heightened awareness within the pharmaceutical industry contribute to the steady expansion of the market, ensuring the integrity and authenticity of pharmaceutical products through innovative and secure packaging solutions.
The increasing emergence of new anti-counterfeiting technologies, such as edible micro tags can only be scanned through the utilization of the manufacturer’s proprietary equipment. It is also helping expand the global anti-counterfeit pharmaceutical packaging market.
Germany’s position as a leader in innovation and technology plays a pivotal role in the expected growth of the anti-counterfeit pharmaceutical packaging industry. With a projected market value of US$ 148.6 billion in 2023, Germany’s pharmaceutical packaging sector is set to thrive. This growth is primarily attributed to the nation’s robust commitment to technological advancements and its reputation for pioneering cutting-edge solutions.
Request Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-2385
The increasing prevalence of counterfeit pharmaceuticals poses a significant threat to public health. As awareness of this issue grows, pharmaceutical companies and regulatory bodies are taking strong measures to combat counterfeiting. It is done through advanced packaging solutions, which in turn drives the demand for anti-counterfeit pharmaceutical packaging.
Continuous advancements in anti-counterfeit technologies have made it feasible and cost-effective for pharmaceutical companies to implement robust security measures. Increasing strict regulation by governments and regulatory agencies for pharmaceutical packaging is likely to drive the market throughout the forecast period.
The growth of online pharmaceutical sales and e-commerce platforms has made it easy for counterfeit drugs to enter the market. E-commerce platforms are adopting anti-counterfeit packaging to protect consumers. The pharmaceutical industry’s continued growth and expansion into emerging markets are driving the need for anti-counterfeit measures.
Key Takeaways
- From 2018 to 2022, the anti-counterfeit pharmaceutical packaging market demand expanded at a CAGR of 6%
- Based on printing technology, the RFID segment is expected to account for a market share of 7.8% during the forecast period.
- Global anti-counterfeit pharmaceutical packaging demand in the United Kingdom is predicted to account for a CAGR of 8.4% through 2033.
- In the United States, the market is expected to account for a CAGR of 8.5% between 2023 and 2033.
- China is projected to expand by a value CAGR of 8.3% through 2033.
- By 2033, India’s anti-counterfeit pharmaceutical packaging market is anticipated to record a CAGR of 8.0%.
“The increasing consumer awareness and expansion of the pharmaceutical industry globally is anticipated to drive the market growth during the forecast period.” says an FMI analyst.
Competitive Landscape
Leading anti-counterfeit pharmaceutical packaging manufacturers increasingly focus on expanding their product offerings to strengthen their customer base. They are adopting growth strategies such as new product launches, partnerships, acquisitions, mergers, collaborations, etc. They expand their global footprint and gain a competitive edge in the market by following these strategies.
Some pharma companies have set up departments whose primary function is safeguarding their brand name from counterfeiting and illicit replication, raising the demand for anti-counterfeit pharmaceutical packaging.
- IBM has been exploring the use of blockchain technology in pharmaceutical supply chains. They have collaborated with various pharmaceutical companies and regulatory bodies to create transparent and secure systems for tracking the provenance of pharmaceutical products
- Systech offers serialization and traceability solutions for pharmaceutical companies. Their platform helps pharmaceutical manufacturers comply with track-and-trace regulations and provides real-time visibility into the supply chain.
- Optel Group provides traceability and serialization solutions for the pharmaceutical industry. They have actively implemented track-and-trace systems to prevent counterfeit drugs from entering the supply chain.
Request Report Methodology: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-2385
Some of the key players in the global anti-counterfeit pharmaceutical packaging market are
- Alien Technology
- ATL Security Label Systems
- CCL Industries
- SICPA Holdings
- Schott AG
- Gerresheimer AG
- Klockner Pentaplast Group
- Ardagh Group S.A.
- Nipro Corporation
- Authentix Inc.
- TruTag Technologies Inc.
- Zebra Technologies Corporation
- Alpvision SA
- OpSec Security Inc.
- Savi Technology Inc.
- 3M
- Stevanato Group.
Market Trends:
- Stringent Regulatory Requirements: Increasing regulations and stringent standards imposed by regulatory bodies to combat counterfeiting in the pharmaceutical industry drive the adoption of anti-counterfeit packaging solutions.
- Rising Incidence of Counterfeiting: The global pharmaceutical industry faces a significant challenge from counterfeit drugs, leading to a heightened demand for effective anti-counterfeit measures to ensure patient safety.
- Brand Protection: Pharmaceutical companies invest in anti-counterfeit technologies to safeguard their brand reputation and protect their intellectual property, thereby maintaining consumer trust.
- Advancements in Technology: Continuous advancements in anti-counterfeit technologies, such as holograms, RFID (Radio-Frequency Identification), QR codes, and tamper-evident packaging, contribute to the growth of the market.
- Globalization of the Pharmaceutical Supply Chain: The expansion of pharmaceutical supply chains across borders increases the risk of counterfeit drugs entering the market, necessitating robust anti-counterfeit measures.
Market Restraints:
- High Implementation Costs: The initial investment required for implementing sophisticated anti-counterfeit technologies can be a barrier, particularly for smaller pharmaceutical companies.
- Complexity of Integration: Integrating anti-counterfeit solutions into existing packaging processes can be challenging and may require significant adjustments, leading to operational complexities.
- Limited Adoption in Developing Regions: Some developing regions may lag in the adoption of anti-counterfeit technologies due to factors such as lower awareness, infrastructure challenges, and budget constraints.
- Resistance to Change: Resistance from traditionalists within the industry who are hesitant to adopt new technologies and processes can hinder the widespread implementation of anti-counterfeit measures.
Buy Now/Purchase: https://www.futuremarketinsights.com/checkout/2385
Key Segmentations:
By Packaging Format :
- Bottles & Jars
- Vials & Ampoules
- Blisters
- Trays
- Pouches & Sachets
- Others (Tubes, Syringes, etc.)
By Printing Technology :
- RFID
- Security Inks & Coatings
- Security Seals
- Holograms
- Mass Encryption
- Barcode
- Mass Serialization
By Adhesion :
- Permanent
- Removable
- Repositionable
By End-application :
- Pharma & Biological
- Medical & Supplies
- Gloves
- Scissors
- Syringes & Needles
- Surgical Tapes
- Others
- Medical Equipment
- Surgical
- Therapeutic
- Diagnostic
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer, Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
